Company news

Lumos Diagnostics Holdings Ltd. news in 2022

Lumos Diagnostics Holdings Ltd.'s news releases, calls and decks from 2022, newest first.

View company

Lumos Secures Two Service Agreements With Hologic

November 22, 2022

LDX signs agreement to raise $8m & announces General Meeting

November 20, 2022

Publication of Data from DISRUPT Clinical Trial in JAMA

October 19, 2022

Lumos Completes Closure of Sarasota Facility

October 2, 2022

Outcome of Appeal to FDA for FebriDx

October 2, 2022

FY22 Full Year Results Media Release

August 25, 2022

FY22 Full Year Results Investor Presentation

August 25, 2022

FY22 Annual Report

August 25, 2022

FY22 Appendix 4E

August 25, 2022

Lumos Pilot Manufacturing to Commence in Carlsbad

August 22, 2022

Lumos Withdraws from Local Manufacturing Proposal

August 8, 2022

Lumos Files Appeal To The FDA For FebriDx

August 7, 2022

Lumos To Close Sarasota Facility

August 1, 2022

Reinstatement to Official Quotation

July 11, 2022

FDA Decision for FebriDx

July 10, 2022

Voluntary Suspension

July 7, 2022

Security Class Reinstatement of Quotation LDXO

June 30, 2022

ViraDx Receives Interim Order Authorisation in Canada

June 26, 2022

Security Class Suspension from Quotation LDXO

June 23, 2022

Lumos Diagnostics Appoints Doug Ward as CEO

June 21, 2022

Lumos secures initial development services contract

June 16, 2022

Successful Completion of Institutional Entitlement Offer

June 7, 2022

Target Market Determination

June 6, 2022

Operational Update and Accelerated Entitlement Offer

June 6, 2022

Operational Review & Management Reorganisation

April 10, 2022

FebriDx Update - Brazil Market Authorisation & New Study

February 27, 2022

FY2022 Half Year Update

February 27, 2022

Lumos Diagnostics FY22 First Half Year Results

February 27, 2022

Change To Lumos Board

February 11, 2022

Victorian Government Intent for Lumos Manufacturing Hub

February 2, 2022

Over 100 Pharmacies in Liverpool UK Launch FebriDx Service

January 11, 2022

Decks in 2022